Immuron Commences US Non-Deal Institutional Investor Roadshow
August 15, 2017 09:15 ET
|
Immuron Limited
MELBOURNE, Australia, Aug. 15, 2017 (GLOBE NEWSWIRE) -- Australian microbiome biopharmaceutical company Immuron Limited (ASX:IMC) (NASDAQ:IMRN) is pleased to release to shareholders and investors...
Immuron Approved to Commence Clinical Study in C.Difficile Infection (CDI)
August 09, 2017 08:30 ET
|
Immuron Limited
Key Highlights Final approval for key first in-human Clinical Study for CDI treatment, by Israeli Ministry of HealthAn estimated 28,000 patients die each year from CDI infections in the USA...
HiberGene Launches HG C. Difficile Test
December 15, 2016 04:55 ET
|
HiberGene Diagnostics Ltd
DUBLIN, Ireland, Dec. 15, 2016 (GLOBE NEWSWIRE) -- HiberGene Diagnostics, a company focussed on applying molecular technology to the infectious disease segment of the diagnostics market, has...